MYGN Expands Cancer Test
Myriad Genetics expands availability of Precise MRD for colorectal, renal, and breast cancers
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Myriad Genetics expands availability of Precise MRD for colorectal, renal, and breast cancers